COVID answers in Scientific Journals all over the world
Publishing House: The Medical Letter, Inc.
15 Results Page 1
[1]
original article
Journal
Date
Title
Authors
Max. 6 Authors
1
[GO]
The Medical Letter on Drugs and Therapeutics
2024―Oct―10
COVID-19
Update: Novavax Vaccine for 2024-2025
2
[GO]
The Medical Letter on Drugs and Therapeutics
2024―Oct―01
Addendum: Effectiveness of mRNA
COVID-19
Vaccines
3
[GO]
The Medical Letter on Drugs and Therapeutics
2024―Sep―19
COVID-19
Update: New Pfizer and Moderna Vaccine Formulations for 2024-2025
4
[GO]
The Medical Letter on Drugs and Therapeutics
2024―May―15
COVID-19
Update: An EUA for Pemivibart (Pemgarda) for Pre-Exposure Prophylaxis
5
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Dec―11
Vaccination Recommendations for Updated 2023-2024
COVID-19
Vaccines
6
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Nov―21
COVID-19
Update: New Novavax Vaccine Formulation for 2023-2024
7
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Oct―03
COVID-19
Update: New Pfizer and Moderna Vaccine Formulations for 2023-2024
8
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Jul―26
Dosing Recommendations for Novavax and Johnson and Johnson
COVID-19
Vaccines
9
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Jul―26
Vaccination Recommendations for Bivalent mRNA
COVID-19
Vaccines
10
[GO]
The Medical Letter on Drugs and Therapeutics
2023―May―11
COVID-19
Update: Metformin to Prevent Long Covid?
11
[GO]
The Medical Letter on Drugs and Therapeutics
2023―May―11
COVID-19
Update: An EUA for Vilobelimab (Gohibic) for
COVID-19
12
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Mar―30
COVID-19
Update: Pfizer Bivalent Vaccine Booster Dose for Children 6 Months to 4 Years Old
13
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Mar―16
Antiviral Drugs for
COVID-19
in Vaccinated Outpatients
14
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Feb―14
COVID-19
Update: Evusheld Unlikely to Neutralize XBB.1.5 Omicron Variant
15
[GO]
The Medical Letter on Drugs and Therapeutics
2023―Jan―17
COVID-19
Update: Tocilizumab (Actemra) FDA-Approved for Treatment of
COVID-19
(online only)
[1]
15 Results Page 1
[
de
][
en
]
Last change 2023―Oct―27 12:08:13 UTC
© Daten-Quadrat 2022 Done in 0.004 sec